Subclinical Anthracycline Cardiotoxicity in Patients With Acute Promyelocytic Leukemia in Long-Term Remission After the AIDA Protocol

Congestive Heart Failure

Volumn 18, Issue 4, 2012, Pages 217-221

  Pellicori, Pierpaolo ^a   Calicchia, Angela ^a   Lococo, Francesco ^a   Cimino, Giuseppe ^a   Torromeo, Concetta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IDARUBICIN; MITOXANTRONE; RETINOIC ACID;

ADULT; AKINESIA; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DYSKINESIA; FEMALE; FOLLOW UP; HEART CYCLE; HEART EJECTION FRACTION; HEART LEFT ATRIUM VOLUME; HEART VENTRICLE WALL MOTION; HEART VOLUME; HUMAN; HYPOKINESIA; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ADULT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARDIOTOXINS; DIASTOLE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; PROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TIME FACTORS; TRETINOIN; YOUNG ADULT;

EID: 84864042079     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00278.x     Document Type: Article

References (38)

1. Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15:1544-1552.
2. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20years after completing anthracycline therapy. JAMA. 1991;266:1672-1677.
3. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
4. Bossi G, Lanzarini L, Laudisa ML, et al. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines. Med Pediatr Oncol. 2001;36:593-600.
5. Sorensen K, Levitt GA, Bull C, et al. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer. 2003;97:1991-1998.
6. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001;19:191-196.
7. Møller JE, Søndergaard E, Poulsen SH, Egstrup K. Pseudonormal and restrictive filling patterns predict left ventricular dilation and cardiac death after a first myocardial infarction: a serial color M-mode Doppler echocardiographic study. J Am Coll Cardiol. 2000;36:1841-1846.
8. Whalley GA, Gamble GD, Doughty RN. Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies. Heart. 2006;92:1588-1594.
9. Kruszewski K, Scott AE, Barclay JL, et al. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide. Am Heart J. 2010;159:47-54.
10. Whalley GA, Gamble GD, Doughty RN. The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis. Int J Cardiol. 2007;116:70-77.
11. Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr. 2001;14:1143-1152.
12. Nikitin NP, Witte KK. Application of tissue Doppler imaging in cardiology. Cardiology. 2004;101:170-184.
13. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol. 2007;49:1903-1914.
14. Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy GIMEMA e AIEOP. Blood. 1997;90:1014-1021.
15. Lo-Coco F, Avvisati G, Vignetti M, et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61years: results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010;116:3171-3179.
16. Sanz MA, Lo Coco F, Martín G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96:1247-1253.
17. Platel D, Pouna P, Bonoron-Adèle S, Robert J. Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model. Anticancer Drugs. 1999;10:671-676.
18. Thomas X, Le QH, Fiere D. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol. 2002;81:504-507.
19. Creutzig U, Zimmermann M, Dworzak M, et al. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. Br J Haematol. 2010;149:399-409.
20. Bristow MR, Billingham ME, Mason JW, Daniels JR. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep. 1978;62:873-879.
21. Billingham ME, Mason JW, Bristow MR, Daniels JR. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978;62:865-872.
22. Mortensen SA, Olsen HS, Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J. 1986;55:274-282.
23. Ewer MS, Ali MK, Mackay B, et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin. J Clin Oncol. 1984;2:112-117.
24. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-2233.
25. Poutanen T, Tikanoja T, Riikonen P, et al. Long term prospective follow up study of cardiac function after cardiotoxic therapy for malignancy in children. J Clin Oncol. 2003;21:2349-2356.
26. Leandro J, Dyck J, Poppe D, et al. Cardiac dysfunction late after cardiotoxic therapy for childhood cancer. Am J Cardiol. 1994;74:1152-1156.
27. Paulides M, Kremers A, Stöhr W, et al. Prospective longitudinal evaluation of doxorubicin induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS). Pediatr Blood Cancer. 2006;46:489-495.
28. Pinarli FG, Oǧuz A, Tunaoǧlu FS, et al. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy. Pediatr Blood Cancer. 2005;44:370-377.
29. van Dalen EC, van der Pal HJ, Kok WE, et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long term follow up study. Eur J Cancer. 2006;42:3191-3198.
30. Park JH, Kim YH, Hyun MC, Kim HS. Cardiac functional evaluation using vector velocity imaging after chemotherapy including anthracyclines in children with cancer. Korean Circ J. 2009;39:352-358.
31. Dodos F, Halbsguth T, Erdmann E, Hoppe UC. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults. Clin Res Cardiol. 2008;97:318-326.
32. Nagy AC, Cserép Z, Tolnay E, et al. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study. Pathol Oncol Res. 2008;14:69-77.
33. Escher F, Westermann D, Gaub R, et al. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart. 2011;97:709-714.
34. Simek CL, Feldman MD, Haber HL, et al. Relationship between left ventricular wall thickness and left atrial size. Comparison with other measures of diastolic function. J Am Soc Echocardiogr. 1995;8:37-47.
35. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284-1289.
36. Zuccalà G, Sgadari A, Cocchi A, et al. Effect of age and pathology on left ventricular diastolic function: the diagnostic yield of Doppler echocardiography. J Gerontol A Biol Sci Med Sci. 1995;50:M78-M82.
37. Galderisi M, Lomoriello VS, Santoro A, et al. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2010;23:1190-1198.
38. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-839.